Skip to main content

Amy Trombly

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Amy Trombly

Amy Trombly is recorded as Board Member at Sonoma Pharmaceuticals, Inc. (SNOA). Sonoma Pharmaceuticals, Inc. reported in an 8-K filed July 22, 2022 that Amy Trombly was appointed member of our Board of Directors, effective July 22, 2022. The proxy statement of Sonoma Pharmaceuticals, Inc. reports total compensation of $741,116 for Amy Trombly in fiscal 2026, including a base salary of $407,500. Disclosed compensation is on record for 7 fiscal years.

“Effective July 22, 2022, the Company’s Board of Directors appointed Amy Trombly, our Chief Executive Officer, to serve as a member of our Board of Directors.”
Sonoma Pharmaceuticals, Inc. Form 8-K, filed July 22, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Sonoma Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 Sonoma Pharmaceuticals, Inc. (SNOA) $407,500 $741,116
2025 Sonoma Pharmaceuticals, Inc. (SNOA) $325,000 $597,075
2024 Sonoma Pharmaceuticals, Inc. (SNOA) $325,000 $726,543
2023 Sonoma Pharmaceuticals, Inc. (SNOA) $318,750 $559,939
2022 Sonoma Pharmaceuticals, Inc. (SNOA) $318,000 $643,000
2021 Sonoma Pharmaceuticals, Inc. (SNOA) $300,000 $580,000
2020 Sonoma Pharmaceuticals, Inc. (SNOA) $153,462 $238,892

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.